Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 8, 2013, Pages 715-722

  Abarca, Eva M ^a   Salmon, Jacklyn H ^a   Gilger, Brian C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; CARBOCYANINE; FLUORESCEIN SODIUM;

ANIMAL TISSUE; AQUEOUS HUMOR; ARTERY PERFUSION; ARTICLE; CHOROID; CILIARY ARTERY; CILIARY BODY; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; EX VIVO STUDY; EXPERIMENTAL PIG; FLUORESCENCE MICROSCOPY; HYDROPHILICITY; INJECTION; IRIS; LENS; LIPOPHILICITY; NONHUMAN; PIGMENT EPITHELIUM; SCLERA; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY; TISSUE DISTRIBUTION; VITREOUS BODY;

ANIMALS; CARBOCYANINES; CHOROID; CILIARY ARTERIES; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCEIN; INTRAVITREAL INJECTIONS; MALE; METABOLIC CLEARANCE RATE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; PERFUSION; REGIONAL BLOOD FLOW; SWINE; TISSUE DISTRIBUTION; VITREOUS BODY;

EID: 84885000655     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0063     Document Type: Article

References (42)

1. Bourges, J.L., Gautier, S.E., Delie, F., et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest. Ophthalmol. Vis. Sci. 44:3562-3569, 2003
2. Pitkanen, L., Ranta, V.P., Moilanen, H., et al. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest. Ophthalmol. Vis. Sci. 46:641-646, 2005
3. Patel, S.R., Lin, A.S., Edelhauser, H.F., et al. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm. Res. 28:166-176, 2011
4. Gaudana, R., Ananthula, H.K., Parenky, A., et al. Ocular drug delivery. AAPS. J. 12:348-360, 2010
5. Cheruvu, N.P., and Kompella, U.B. Bovine and porcine transscleral solute transport: influence of lipophilicity and the choroid-Bruch's layer. Invest. Ophthalmol. Vis. Sci. 47:4513-4522, 2006
6. Seiler, G.S., Salmon, J.H., Mantuo, R., et al. Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes. Invest. Ophthalmol. Vis. Sci. 52:5730-5736, 2011
7. Olsen, T.W., Feng, X., Wabner, K., et al. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Invest. Ophthalmol. Vis. Sci. 52:4749-4756, 2011
8. Einmahl, S., Savoldelli, M., D'Hermies, F., et al. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest. Ophthalmol. Vis. Sci. 43:1533-1539, 2002
9. Cho, S.W., and Olsen, T.W. Drug delivery to the suprachoroidal space. In: Thassu, D., and Chader, G.J., eds. Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2013; p. 235-258
10. Brubaker, R.F., and Pederson, J.E. Ciliochoroidal detachment. Surv. Ophthalmol. 27:281-289, 1983
11. Patel, S.R., Berezovsky, D.E., McCarey, B.E., et al. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest. Ophthalmol. Vis. Sci. 53:4433-4441, 2012
12. Gilger, B.C., Wilkie, D.A., Clode, A.B., et al. Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis. Vet. Ophthalmol. 13:294-300, 2010
13. Gilger, B.C., Salmon, J.H., Wilkie, D.A., et al. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest. Ophthalmol. Vis. Sci. 47:2596-2605, 2006
14. Olsen, T.W., Feng, X., Wabner, K., et al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am. J. Ophthalmol. 142:777-787, 2006
15. Kim, S.H., Galban, C.J., Lutz, R.J., et al. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. 48:808-1412, 2007
16. Edelhauser, H.F., Rowe-Rendleman, C.L., Robinson, M.R., et al. Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest. Ophthalmol. Vis. Sci. 51:5403-5420, 2010
17. Almazan, A., Lee, S.S., Ross, A.D., et al. Barriers to transscleral drug delivery to the retina. In: Thassu, D., and Chader, G.J., eds. Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2013; p. 133-149
18. Kim, H., Robinson, M.R., Lizak, M.J., et al. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. 45:2722-2731, 2004
19. Amrite, A.C., Edelhauser, H.F., Singh, S.R., et al. Effect of circulation on the disposition and ocular tissue distribution of 20nm nanoparticles after periocular administration. Mol. Vis. 14:150-160, 2008
20. Bill, A. Blood circulation and fluid dynamics in the eye. Physiol. Rev. 55:383-417, 1975
21. Koeberle, M.J., Hughes, P.M., Skellern, G.G., et al. Pharmacokinetics and disposition of memantine in the arterially perfused bovine eye. Pharm. Res. 23:2781-2798, 2006
22. Shiels, I.A., Sanderson, S.D., and Taylor, S.M. Arterially perfused eye model of uveitis. Aust. Vet. J. 77:100-104, 1999
23. Shahidullah, M., Chan, H.H.L., Yap, M.K., et al. Multifocal electroretinography in isolated arterially perfused bovine eye. Ophthalmic. Physiol. Opt. 25:27-34, 2005
24. Wilson, W.S., Shahidullah, M., and Millar, C. The bovine arterially-perfused eye: an in vitro method for the study of drug mechanisms on IOP, aqueous humour formation and uveal vasculature. Curr. Eye Res. 12:609-620, 1993
25. Li, S.K., Molokhia, S.A., and Jeong, E.K. Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging. Pharm. Res. 21:2175-2184, 2004
26. Robinson, M.R., Lee, S.S., Kim, H., et al. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp. Eye Res. 82:479-487, 2006
27. Mains, J., Wilson, C.G., and Urquhart, A. ToF-SIMS analysis of dexamethasone distribution in the isolated perfused eye. Invest. Ophthalmol. Vis. Sci. 52:8413-8419, 2011
28. Berezovsky, D.E., and Edelhauser, H.F. Transscleral and suprachoroidal drug delivery. In: Thassu, D., and Chader, G.J. Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2013; p. 179-190
29. Zane, P.A., Brindle, S.D., Gause, D.O., et al. Physicochemical factors associated with binding and retention of compounds in ocular melanin in rats: correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses. Pharm. Res. 7:935-941, 1990
30. Kadam, R.S., Cheruvu, N.P., Edelhauser, H.F., and Kompella, U.B. Sclera-Choroid-RPE transport of eight-blockers in human, bovine, porcine, rabbit, and rat models. Invest. Ophthalmol. Vis. Sci. 52:5387-5399, 2011
31. Pescina, S., Santi, P., Ferrari, G., et al. Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery. Eur. J. Pharm. Sci. 46:475-483, 2012
32. Tyagi, P., Kadam, R.S., and Kompella, U.B. Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry. PLoS One. 7:e48188, 2012
33. Sanchez, I., Martin, R., Ussa, F., et al. The parameters of the porcine eyeball. Graefes Arch. Clin. Exp. Ophthalmol. 249:475-482, 2011
34. Tsuboi, S., Fujimoto, T., Uchihori, Y., et al. Measurement of retinal permeability to sodium fluorescein in vitro. Invest. Ophthalmol. Vis. Sci. 25:1146-1150, 1984
35. Tsuboi, S., and Pederson, J.E. Permeability of the isolated dog retinal pigment epithelium to carboxyfluorescein. Invest. Ophthalmol. Vis. Sci. 27:1767-1770, 1986
36. Kimura, M., Araie, M., and Koyano, S. Movement of carboxyfluorescein across retinal pigment epithelium-choroid. Exp. Eye Res. 63:51-56, 1996
37. Booij, J.C., Baas, D.C., Beisekeeva, J., et al. The dynamic nature of Bruch's membrane. Prog. Retin. Eye Res. 29:1-18, 2010
38. Gouras, P., and Hoff, M. Retinal function in an isolated perfused mammalian eye. Invest. Ophthamol. Vis. Sci. 9:388-399, 1970
39. Niemeyer, G. Retinal research using the perfused mammalian eye. Prog. Retin. Eye Res. 20:289-318, 2001
40. Coo, F.A., Zonnenberg, B.A., and Trap, N.H. Prolonged normothermic perfusion of the isolated bovine eye: initial results. Curr. Eye Res. 12:293-301, 1993
41. Lansel, N., and Niemeyer, G. Effects of insulin under normal and low glucose on retinal electrophysiology in the perfused cat eye. Invest. Ophthamol. Vis. Sci. 38:792-799, 1997
42. Lee, S.J., He, W., Shaun, B., et al. Evaluation of clearance mechanisms with transscleral drug delivery. Invest. Ophthalmol. Vis. Sci. 51:5205-5212, 2010.